CANTEL MEDICAL CORP. (NYSE:CMD) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As previously disclosed, on November 10, 2016, Cantel Medical Corp. (Company) announced that Steven C. Anaya, the then Senior Vice President and Chief Accounting Officer of the Company, would be departing the Company. Mr. Anaya’s last day with the Company was on June 9, 2017.
On June 9, 2017, Brian Capone, Vice President and Corporate Controller of the Company, was named principal accounting officer. Mr. Capone, age 42, joined the Company on April 17, 2017. Prior to that, Mr. Capone served at Stryker Corporation, a medical device company, as the Assistant Corporate Controller from October 2014 through April 2017 and as Director, External Financial Reporting/Technical Accounting at Quest Diagnostics, a clinical lab and diagnostic testing company from April 2012 through October 2014. For more than ten years prior thereto, Mr. Capone served in various finance and accounting positions at both private and public companies. Mr. Capone is a CPA in the state of New York.